Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Learn the 7 things “alphas” should know to protect their health while managing a rare disease that can affect the lungs and l…
Children and teens who live with hemophilia and other bleeding disorders work hard to achieve a milestone: mastering the art …
U.S. medical experts authorize an additional booster for some people with immune system problems to keep their defenses up ag…
U.S. regulators have cleared a new device designed to collect plasma more quickly and improve the experience for both plasma …
For the second time in three years, Farina has been recognized as a top Global In-house Professional by PR Week, the world’s …
Morris is a Senior Production Manager for Seqirus, ensuring influenza vaccine gets out the door to protect public health. At …
For Doctors’ Day, we asked patients – and a few of our on-staff physicians: What’s the best advice you ever received from a d…
The 1983 U.S. Orphan Drug Act energized innovation and led to new treatments for rare conditions that had been “orphaned” bec…
Unleashing artificial intelligence on thousands of lung scans could lead to breakthroughs for people who have pulmonary fibro…
Americas
Asia Pacific
Middle East
Europe